September 2009
Hetero Drugs headquartered in Hyderabad, India and the parent company of Camber Pharmaceuticals Inc., Piscataway New Jersey, is one of the global pharmaceutical manufacturing companies leading a major effort against the worldwide Swine Flu epidemic (H1N1).
Hetero Drugs is sub-licensed by Swiss pharmaceutical giant Roche, (the manufacturer of Tamiflu - the most widely used pharmaceutical product to cure swine flu), to manufacture and market Oseltamivir (generic Tamiflu) for both active pharmaceutical ingredient (API) and finished product for supply to India, and other non-U.S. countries world wide.
These articles listed below are just a few that have been published since Roche and Hetero signed their agreement.
Please visit these links to read about Hetero Drugs involvement in trying to help end this worldwide health problem.
Initial Articles:
December 2005 -
http://www.roche.com/med-cor-2005-12-23
December 2005 -
http://redherring.com/Home/15025
More Recent articles:
March 31, 2009 -
http://www.pharmaceuticalonline.com/article.mvc/Hetero-Signs-Agreement-With-Roche-For-Tamiflu-0001?VNETCOOKIE=NO
April 30, 2009 -
http://www.business-standard.com/india/news/hetero-drugs-gets-govt-order-to-supply-tamiflu/356665/
August 21, 2009 -
http://www.business-standard.com/india/news/hyderabad-firm-delivers-anti-swine-flu-drug/71433/on
We at Camber and Hetero recognize the importance of this issue and have listed important information concerning Swine Flu below for your review.
Some facts about Swine Flu-What is swine flu?
Swine Influenza (swine flu) is a respiratory disease of pigs caused by type A influenza viruses that causes regular outbreaks in pigs. People do not normally get swine flu, but human infections can and do happen. Swine flu viruses have been reported to spread from person-to-person, but in the past, this transmission was limited and not sustained beyond three people.
Is this swine flu virus contagious?
CDC has determined that this swine influenza A (H1N1) virus is contagious and is spreading from human to human. However, at this time, it is not known how easily the virus spreads between people.
How does swine flu spread?
Spread of this swine influenza A (H1N1) virus is thought to spread in the same way as the seasonal flu virus. Flu viruses are spread mainly from person to person through coughing or sneezing of people with influenza. Sometimes a person may become infected by touching something with flu viruses on it and then touching their mouth or nose.
What can you do to help protect yourself?
- Cover your nose and mouth with a tissue when you cough or sneeze. Throw the tissue in the trash after you use it. If you don't have a tissue, cough into your elbow.
- Wash your hands often with soap and water, especially after you cough or sneeze. Alcohol-based hands cleaners are also effective.
- Avoid touching your eyes, nose or mouth. Germs spread that way.
- Use disinfectants on frequently touched surfaces. Germs can also be spread when a person touches an infected surface and then touches their own eyes, mouth or nose.
Additional Information:
CDC Swine Flu:
www.cdc.gov/swineflu
WHO Swine Flu FAQs:
www.who.int/csr/disease/swineflu/faq/en/index.html
Camber Pharmaceuticals Inc.
http://www.camberpharma.com , Invagen Pharmaceuticals, Inc
http://www.invagen.com and Hetero Drugs
http://www.heterodrugs.com
September 2009
Piscataway, NJ - Camber Pharmaceuticals Inc. is proud to announce the introduction and availability of Torsemide tablets. Camber Torsemide tablets are AB rated and bioequivalent to Demadex tablets. Camber Torsemide tablets are available in 5mg, 10mg, 20mg, and 100mg strengths in bottle sizes of 100.
August 2009
Boston, Massachusetts - Camber Pharmaceuticals Inc. named Walmart, headquartered in Bentonville, Arkansas, its customer of the year for 2009 at the recent National Association of Chain Drug Stores (NACDS) conference. Camber Pharmaceuticals Inc., one of the industries fastest growing generic companies, was pleased to award Walmart with its Customer of the Year award for being its top retailer. The award was given to Walmart based on the retailer's sales growth with Camber, its business practices, its "partnership" and long term strategic relationship with Camber. The inaugural 2008 winner of the Camber Retail Customer of the year was Kinray Inc. a HDMA wholesaler headquartered in Whitestone, NY.
August 2009
Camber Pharmaceuticals Inc., a generic sales and marketing company and wholly owned subsidiary of Hetero Ltd. Hyderabad India, will be in attendance at the "NACDS" Pharmacy & Technology Conference in Boston, Massachusetts August 8-11, 2009. Camber will be unveiling a new corporate branding campaign that will build awareness of the fast growing company as it expands its presence in the US generics marketplace. The Camber booth is located at # 695 on the convention center floor. While attending the conference, Camber will be meeting with high level executives from national and regional retail chain companies to discuss their current and future sales and marketing plans and explore other strategic opportunities.
To schedule an appointment to meet with a Camber representative please contact Megan Hinman or Kon Ostaficiuk at (732) 377-2029. While at the convention, Camber will be one of the generic sponsors hosting the annual "Monday Night Party - Pharm Aid '09" which will be held at the Parris Lounge at Ned Devine's located in Boston's historic Faneuil Marketplace. We hope to see you there!
March 2009
Camber Pharmaceuticals, Inc. is pleased to announce
Mr. Kon Ostaficiuk has joined Camber as our
Vice President of Sales and Marketing. As you know Kon is a valued industry professional and has over twenty years experience in the sales and marketing of both branded and generic pharmaceuticals.
Kon brings a wealth of generic pharmaceutical knowledge and expertise to our existing Camber management and sales team. Kon will help strengthen and oversee Camber's growing commercial sales and marketing efforts, as well as customer service, contracts and supply chain logistics. As always, Camber appreciates your business and continued support. We are excited that Kon has joined our team.
Kon and I look forward to seeing or speaking with you all very soon to discuss our current Camber product line and our exciting new product launch opportunities coming very soon. Please join us in welcoming Kon Ostaficiuk to Camber's growing team of professionals.
Contact Kon to discuss Camber and our numerous product growth opportunities
September 2008
PISCATAWAY, N.J. - Camber Pharmaceuticals Inc., which opened offices here just over a year ago, is an emerging generic pharmaceutical and sales and marketing organization backed by Hetero Drugs Ltd., one of India's largest active pharmaceutical ingredient (API) suppliers.
Camber is already supplying generics in therapeutic categories from antihypertensives to antiretrovirals. Through Hetero, Camber will have access to the full range of antiretrovirals in the President's Emergency Plan for AIDS Relief (PEPFAR) program, says Camber president Briggs Arrington. Companies that participated in the initiative receive special consideration for approval as those antiretrovirals become available in the United States. Camber is one of a very few international companies with access to the full line of antiretrovirals and their APIs. Hetero is currently marketing most of the known antiretrovirals for the Asian and African AIDS markets already, Arrington notes.
"As those drugs become available in the U.S., Camber, through its parent Hetero, will be able to provide a full line of the antiretrovirals economically by being vertically integrated utilizing its own APIs," he says, adding that Camber's closed and controlled supply chain means reliability of supply and cost efficiencies for the marketplace.
Arrington points out that Camber can access more than 150 process patents for APIs and more than 100 drug master files (DMFs) in regulated markets. The company has the potential to bring to market over 250 finished dosage formulations, including tablets, capsules, liquids, soft gels and injectables.
Utilizing Hetero's finished dosage manufacturing facility on Long Island, Camber has a solid U.S. manufacturing base, but that is only half of the story. Hetero early next year expects to complete a 125,000-square-foot FDA-approved facility in India dedicated to the American finished dosage market. With a capacity of over 5 billion tablets, it will be one of the largest Indian finished-dosage manufacturing facilities dedicated to the U.S. generics market. Having manufacturing facilities on two continents will give Camber the service flexibility on key products it needs to ensure an uninterrupted supply, according to Arrington. Buyers want reliability of supply above all else, he adds.
Using the expertise of logistics partner DDN Obergfel, Camber is marketing its line to a broad customer base with complete on-time delivery at a considerable savings, says Arrington. To enhance its positioning, the company is building a management team that knows and understands the American generics market. Megan Hinman was named manager of sales operations in 2007, and Brett Barczak was appointed director of national accounts early this year. Most recently, industry veteran Laura Ciardi has joined Camber to become director of corporate accounts.
"Members of this team are young, energetic, innovative and devoted," Arrington comments. "They're terrific people capable of telling the Camber story with great integrity. I'm proud to be associated with them.
"Our goal is to continue to bring a broad line of generic products forward in 2009 and 2010," he says. "We will be a major player in the U.S. generics finished-dosage market, but we've only just begun."
Camber Pharmaceuticals Inc.
A POSITIVE ANGLE ON GENERICS
200 Centennial Ave.
Piscataway, N.J. 08854-3950
Key contact: MEGAN HINMAN, Manager of Sales Operations
Phone: (732) 377-2029 / Fax: (732) 377-2067
www.camberpharma.com
January 2008
We are looking for 2008 to be our "Camber Break Out Year." We're pleased to tell you about our growing team of industry professionals.
Joining Camber as our
Manager of Sales Operations is a wonderful new addition,
Megan Hinman. Many of you will know Megan from her professional experience at Granard Pharmaceutical Sales and Marketing. Megan brings a wealth of talent and will be effective both on inside sales operations and calling on strategic accounts.
Camber is also welcoming
Brett Barczak to the team. Brett will be joining Camber as
Director of National Accounts effective December 1, 2007. Brett is a veteran in the generic industry with many successful years of experience, most recently with Genpharm. With Brett and Megan in place you can see why we expect 2008 to be our break out year!
